On August 11, 2026, JPMorgan Chase & Co. sold 953,266 shares of PHARMARON (03759) H shares at an average of HKD 29.33 per share, involving about HKD 27.96 million.
Prior to the disposal, JPMorgan Chase & Co.'s long position in PHARMARON was 29.08 million shares, representing 8.07%; following the disposal, the holding changed to 28.12 million shares, with the long position ratio falling to 7.81%.